To page body
university of tampere: faculty of medicine and life sciences: research:
Faculty of Medicine and Life SciencesUniversity of TampereFaculty of Medicine and Life Sciences

Pathology

Professor:
Timo Paavonen
tel. +358 50 443 7259
timo.paavonen@uta.fi

Reseach groups of the Department of Pathology (in collaboration with University Hospital; Fimlab Laboratories and Heart Cencer)

Immunologic pathogenesis of ascending aortic aneurysm
Group leaders: Prof.Timo Paavonen, doc Ari Mennander et al.

We are investigating the interactions of ascending aortic wall aneurysm, dissection, overall degeneration and aortic wall inflammation. The components of aortic inflammatory reactions are studied in detail, for example the role of c4d complement component and IgG4, as well as many other important regulators of inflammation. The correlation with aortic valve changes are taken into accaunt. The clinical correlations and survival data will be analysed.

Brain tumor reseach
Group leader: Doc Hannu Haapasalo

Doc Haapasalo is leading a reseach group concentrating in brain tumor markers and gene expression.  They want find new reliable diagnostic methods, and molecules for targeted personalized treatment via revealing new pathogenetic mechanisms in brain tumor development. They are using modern methods of translational medicine. The exellent results and productivity of this group is based on multidiciplinary collaboration between pathology, cancer genetics, neurosurgery, oncology and clinical genetics. Advantage is also  broad national and international collaboration.

Diagnostic and prognostic markers of thyroid tumors
Group leader: Doc Ivana Kholová

The frequency thyroid cancer is increasing, and though its usually benign nature, relapsis can be rather common. The Kholova group is concentrating in finding new tumor markers which can predict the behavior and biologic aggressiveness of these tumors. They are also trying to find diagnostic aid to solve the complicated differential diagnostics between follicular thyroid adenoma and cancer.

Prostate cancer study
Doc Paula Kujala

Prostate cancer incidence is high. Many histological cancer lesions will never develop to a clinical cancer. What is the diffenece between these slow growing lesions and metastasing aggressive prostate cancer.  The Tampere Prostate Cancer Reseach Cencer is solving questions arising for example from this dilemma. Doc Kujala is the leading pathologist in this group.

 

 
Maintained by: med.info@uta.fi
Last update: 24.2.2014 9.45 Muokkaa

University of Tampere
+358 3 355 111
registry@uta.fi


FINEEC Audited HR Excellence in Research

THE UNIVERSITY
Research
Admissions
Studies
News
Cooperation and Services
About Us

CURRENT ISSUES
Research & Study
Tampere3
Vacancies

SERVICES
Administration
Career Services
Finnish Social Science Data Archive
Centre for International Education
IT services
Language Centre
Language Services
Library
Registrar's Office
Registry
Sports Activities
» more

STUDIES
Teaching schedules
Curricula guides
Student's Desktop

ONLINE SERVICES
Andor search
Renew your loans
UTA intranet
Office 365 webmail
Uta webmail
Moodle
NettiOpsu
NettiKatti
TamPub
Electronic exam service
Examination results